C
2.02
-0.09 (-4.50%)
前收盘价格 | 2.11 |
收盘价格 | 2.09 |
成交量 | 2,530,299 |
平均成交量 (3个月) | 5,776,693 |
市值 | 297,665,888 |
价格/销量 (P/S) | 0.860 |
股市价格/股市净资产 (P/B) | 0.690 |
52周波幅 | |
利润日期 | 7 Feb 2025 |
营业毛利率 | -201.27% |
营业利益率 (TTM) | -33.63% |
稀释每股收益 (EPS TTM) | -4.94 |
季度收入增长率 (YOY) | -9.50% |
总债务/股东权益 (D/E MRQ) | 120.38% |
流动比率 (MRQ) | 1.39 |
营业现金流 (OCF TTM) | -160.26 M |
杠杆自由现金流 (LFCF TTM) | -29.27 M |
资产报酬率 (ROA TTM) | -4.39% |
股东权益报酬率 (ROE TTM) | -93.03% |
市场趋势
短期 | 中期 | ||
行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 混合的 |
Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 混合的 | |
股票 | Canopy Growth Corporation | 混合的 | 看跌 |
AIStockmoo 评分
0.2
分析师共识 | NA |
内部交易活动 | NA |
价格波动 | 0.5 |
技术平均移动指标 | 2.5 |
技术振荡指标 | -2.5 |
平均 | 0.17 |
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials. |
|
部门 | Healthcare |
行业 | Drug Manufacturers - Specialty & Generic |
投资方式 | Small Core |
内部持股比例 | 0.13% |
机构持股比例 | 6.26% |
所有权
姓名 | 日期 | 持有股份 |
---|---|---|
Parallax Volatility Advisers, L.P. | 30 Sep 2024 | 276,870 |
Engineers Gate Manager Lp | 30 Sep 2024 | 121,422 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合